Chapman Global Medical Center, INC
Chapman Global Medical Center, INC was paid $761K by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 0450, Emergency room services — 18% of everything it billed.
ORANGE, CA 92869
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,082 | $65K | |
| 2019 | 10,195 | $125K | |
| 2020 | 8,225 | $81K | |
| 2021 | 9,218 | $66K | |
| 2022 | 12,787 | $120K | |
| 2023 | 10,201 | $134K | |
| 2024incomplete | 7,577 | $171K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 18% | 10,069 | 8,992 | $133K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 10% | 1,913 | 1,464 | $79K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10% | 1,936 | 1,709 | $78K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8.6% | 1,777 | 1,402 | $65K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.6% | 1,454 | 1,231 | $35K |
| 80053 | Comprehensive metabolic panel | 4.4% | 5,171 | 4,591 | $34K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 624 | 576 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 5,252 | 4,611 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.7% | 2,195 | 1,971 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.7% | 1,639 | 1,426 | $28K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.5% | 320 | 295 | $26K |
| 99199 | Unlisted special service, procedure or report | 2.4% | 309 | 297 | $18K |
60 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 847 | $17K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2.3% | 2,620 | $17K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 1,257 | $17K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 2,067 | $15K |
| J3490 | Unclassified drugs | 1.7% | 3,144 | $13K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.5% | 2,356 | $12K |
| 84484 | 1.4% | 1,796 | $11K | |
| 83690 | 1.3% | 2,279 | $10K | |
| Z7502 | 1.1% | 234 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.0% | 1,906 | $8K |
| 81025 | <1% | 2,165 | $5K | |
| 81001 | <1% | 2,703 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 742 | $4K |
| 99283 | Emergency room visit (moderate) | <1% | 428 | $4K |
| 87631 | <1% | 139 | $4K | |
| 0270 | <1% | 4,756 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 69 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 262 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 251 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 33 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 203 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 93 | $1K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 68 | $939.87 |
| J2704 | Injection, propofol, 10 mg | <1% | 283 | $795.32 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 243 | $770.86 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 51 | $748.07 |
| 85610 | <1% | 358 | $685.05 | |
| 85027 | <1% | 131 | $612.51 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 145 | $547.30 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 84 | $530.04 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 87 | $472.74 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $383.10 |
| 83880 | <1% | 28 | $380.70 | |
| 83605 | <1% | 42 | $374.52 | |
| 82948 | <1% | 134 | $339.34 | |
| 82150 | <1% | 109 | $318.53 | |
| 90715 | <1% | 12 | $310.23 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 73 | $287.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 72 | $281.56 |
| 85730 | <1% | 92 | $249.99 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 32 | $244.84 |
| 85380 | <1% | 61 | $206.75 | |
| Z7610 | <1% | 24 | $157.97 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 33 | $145.12 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 17 | $138.73 |
| 82550 | <1% | 65 | $138.03 | |
| 0360 | <1% | 390 | $101.90 | |
| 82553 | <1% | 14 | $74.58 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $72.43 |
| 0710 | <1% | 294 | $54.66 | |
| 0250 | <1% | 211 | $6.48 | |
| 0100U | <1% | 25 | $5.71 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 577 | $2.06 |
| 0352 | 0% | 13 | $0.00 | |
| 0324 | 0% | 13 | $0.00 | |
| 0636 | 0% | 35 | $0.00 | |
| 0300 | 0% | 312 | $0.00 | |
| 99001 | 0% | 76 | $0.00 | |
| 0260 | 0% | 25 | $0.00 | |
| 0320 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| KPC Global Medical Centers, INC. | Hemet, CA | $29.34M |
| Victor Valley Hospital Acquisition, INC. | Victorville, CA | $26.63M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Orange County Global Medical Center, INC | Santa Ana, CA | $8.60M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| Anaheim Global Medical Center, INC | Anaheim, CA | $4.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $3.98M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.